E-resources
-
Ignatowska-Jankowska, Bogna; Wilkerson, Jenny L; Mustafa, Mohammed; Abdullah, Rehab; Niphakis, Micah; Wiley, Jenny L; Cravatt, Benjamin F; Lichtman, Aron H
The Journal of pharmacology and experimental therapeutics, 05/2015, Volume: 353, Issue: 2Journal Article
The endogenous cannabinoid 2-arachidonoylglycerol (2-AG) plays an important role in a variety of physiologic processes, but its rapid breakdown by monoacylglycerol lipase (MAGL) results in short-lived actions. Initial MAGL inhibitors were limited by poor selectivity and low potency. In this study, we tested JZL184 4-nitrophenyl 4-bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methylpiperidine-1-carboxylate and MJN110 2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate, MAGL inhibitors that possess increased selectivity and potency, in mouse behavioral assays of neuropathic pain chronic constriction injury (CCI) of the sciatic nerve, interoceptive cannabimimetic effects (drug-discrimination paradigm), and locomotor activity in an open field test. MJN110 (1.25 and 2.5 mg/kg) and JZL184 (16 and 40 mg/kg) significantly elevated 2-AG and decreased arachidonic acid but did not affect anandamide in whole brains. Both MAGL inhibitors significantly reduced CCI-induced mechanical allodynia with the following potencies ED50 (95% confidence limit CL) values in mg/kg: MJN110 (0.43 0.30-0.63) > JZL184 (17.8 11.6-27.4) and also substituted for the potent cannabinoid receptor agonist CP55,940 2-(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl-5-(2-methyloctan-2-yl)phenol in the drug-discrimination paradigm ED50 (95% CL) values in mg/kg: MJN110 (0.84 0.69-1.02) > JZL184 (24.9 14.6-42.5); however, these compounds elicited differential effects on locomotor behavior. Similar to cannabinoid 1 (CB1) receptor agonists, JZL184 produced hypomotility, whereas MJN110 increased locomotor behavior and did not produce catalepsy or hypothermia. Although both drugs substituted for CP55,940 in the drug discrimination assay, MJN110 was more potent in reversing allodynia in the CCI model than in producing CP55,940-like effects. Overall, these results suggest that MAGL inhibition may alleviate neuropathic pain, while displaying limited cannabimimetic effects compared with direct CB1 receptor agonists.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.